Is ORXCF undervalued? Our fair value estimate

ORIX Corporation · Financial Services · PNK

Our fair value estimate
USD25.15
Current share price
USD39.84
Downside to fair value
-36.9%
Screens as clearly overvalued. ORIX Corporation trades 37% above the USD25.15 our model puts on the business. A fair value estimate is an argument, not a measurement: it is only as good as its growth assumption, and the market is frequently right about why something trades where it does.
Overall rating: 42/100, ReduceMoat score: 59/100Data quality: high confidence (100/100 of the inputs on file)

How we got here

The estimate is computed from ORXCF's reported fundamentals, with a growth assumption that is deliberately capped: small changes to an uncapped growth or terminal assumption can justify any price, and a number that can justify anything means nothing. These are the inputs the model holds for ORXCF today; the exact method, and where it goes wrong, is on the methodology page.

Earnings multiple16.8x

The starting point is earnings power: what the business earns per share, and what the market currently pays for each unit of it.

Revenue growth (YoY)+28.0%

The trailing growth rate informs the growth assumption, which the model caps deliberately: uncapped growth assumptions can justify any price.

Profit margin13.4%

Margins tell the model how much of each unit of revenue survives as profit, and how much room there is for that to erode.

Return on equity10.4%

Persistent high returns on capital are what a moat looks like in the accounts, and they feed the moat score alongside the valuation.

Beta0.72

A volatility measure against the wider market. A jumpier share earns a larger discount for risk, which lowers the estimate.

Debt to equity1.48

Leverage haircuts the estimate: debt claims cash before shareholders do, and it turns bad years into dangerous ones.

The belief gap: what growth this price asks you to believe

Run our DCF backwards and every price becomes a growth assumption. One axis compares them: today's market price, the entry prices implied by super investors' 13F filings, the mean analyst target, and the growth our own model funds. The gap between the market's marker and the cohort's markers is the growth you are being asked to believe that informed buyers did not need.

Our model5.0%Market16.1%
0% growth19% annual cash-flow growth

Today's price asks you to believe about 16.1% annual cash-flow growth. Our model funds 5.0%.

Entry prices are filing-implied averages (reported position value divided by reported shares for the quarter a position was opened or materially increased), not actual cost bases; 13Fs lag by up to 45 days. How the Belief Gap is computed.

Common questions

Is ORIX Corporation (ORXCF) undervalued?

On our model, ORXCF at USD39.84 trades 37% above our fair value estimate of USD25.15, so it screens as overvalued today. That is one model's answer, not a recommendation: a fair value estimate is an argument about the future, and the market is frequently right about why something is cheap.

What is the fair value of ORXCF?

Our current fair value estimate for ORIX Corporation is USD25.15 per share. The estimate moves as prices and fundamentals move.

How is ORXCF's fair value calculated?

From ORIX Corporation's reported fundamentals: earnings power, a deliberately capped growth assumption, and a discount for balance sheet and volatility risk. The full method, including its known weaknesses, is published on our methodology page, and the interactive Valuation Lab lets you change every assumption and watch the value move.

Disagree with an assumption? Good. The Valuation Lab on the ORXCF app page puts every input of this model on a slider, including a reverse DCF that shows the growth the market is currently pricing in.

A fair value estimate is a model output computed from company filings and market data, refreshed daily; quotes are delayed. It is educational information, not financial advice and not a recommendation to buy or sell anything. Read the full disclaimer.